medigraphic.com

2010, Number 3

<< Back Next >>

Rev Mex Anest 2010; 33 (3)

Anesthesia in Steinert muscular dystrophy

Oriol-López SA, Hernández-Bernal CE

Language: Spanish
References: 30
Page: 160-165
PDF size: 276.95 Kb.


ABSTRACT

The Steinert, disease has an incidence worldwide Muscular Dystrophies is 1: 8,000 births in Mexico there is no report, often associated with problems anesthetics such as the use of inhaled anaesthetics, neuromuscular blockers and even malignant, by the infrequency of suffering hyperthermia, when faced with a patient with some clinical features of this kind, we wonder, what the anesthetic procedure which will have fewer consequences? The clinical case of 33 years bearer of Steinert disease, with diabetes mellitus, atrophy muscle, gonadal, fall of hair and irritability, who was made cantopexia, with local anesthesia and sedation occurs. We conducted a literature review.


REFERENCES

  1. Bird TD. Myotonic dystrophy type 1 (Steinert´s Disease). Gene reviews. www.genetests.org acceso noviembre 15, 2008.

  2. Hayward LJ, Brown Jr RH, Cannon SC. Slow inactivation differs among mutant Na channels associated with myotonia and periodic paralysis. Biophysical Journal 1997;72:1204-1219.

  3. Thormton Ch, Ashizawa T. Getting a grip on the myotonic dystrophies. Neurology 1999;52:12-13.

  4. 4) Canales RJ, Parejo GS. Enfermedad de Steinert: diagnóstico a partir de una arritmia ventricular. Medifam 2002;12:348-350.

  5. Mathiew J, Allard P, Potvin L, Présvost C, Bégin P. A 10 year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 1999;52:1658-1668.

  6. Pelargonio G, Russo AD, Sanna T, De Martino G, Belloci F. Myotonic dystrophy and the heart. BJM Heart 2002;88:665-670.

  7. Bellini M, Biagi S, Stasi C, Costa F, Mumolo MG, Ricchiuti A, Marchi S. Gastrointestinal manifestations in myotonic muscular dystrophy World J Gastroenterol 2006;12:1821-1828.

  8. Bueno JL, Serralta AS, Ballester CI, Planeéis MR, Galeano JS, Rodero DR. Perforación colónica secundaria a distrofia miotónica de Steinert. Cir Esp 2003;73:375-377.

  9. Antonioni G, Mainero C, Romano A, Giubilei F, CeschinV, Gragnani F, Morino S, Fiorelli M, Soscia F, Di Pasquale A, Caramia F. Cerebral atrophy in myotonic dystrophy: a voxel based morphometric study. J Neurol Neurosug Pysichitry 2004;75:1611-1613.

  10. Stoelting and Deerdofs. Chapter 26 Skin and musculoskeletal diseases. In: Anesthesia and Co-Existing diseases, 3a. Edition, 1993.

  11. Miller y Lee Ch. Capítulo 14. Enfermedades de los músculos, en anestesia en enfermedades poco frecuentes. Correlaciones fisiopatológicas y clínicas. 2ª. Edición, Salvat Editores, 1984:560-572.

  12. Meola G. Myotonic dystrophies, Current Opinion in Neurology 2000;13:510-525.

  13. Perseghin G, Caumo A, Arcelloni C, et al. Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. Diabetes Care 2003;26:2112-2118.

  14. Catena V, Del Monte DD, Rubini A, Guccione C, Ricgana F, Gangeri G, De Zen GF. Anestesia and myotonic dystrophy (Steinert´s Syndrome). The role of total intravenous anesthesia with propofol, cisatracurium and remifentanyl. Case report. Minerva Anestesiol 2007;73:475-479.

  15. Bennun M, Goldstein B, Finkelstein Y, Jedeiken R. Continuous propofol anaesthesia for patients with myotonic dystrophy. Br J Anaesth 2000;85:407-409.

  16. White DA, Smith BA. Continuous infusion of propofol in dystrophia myotonica Can J Anaesth 1989;36:200-203.

  17. Mathiew J, Allard P, Gobeil G, Girard M, De Braekeleer M, Bégin P. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology 1997;49:1646-1650.

  18. 18 Takhar AS, Thaper A, Byrne A, Lobo ND. Laparoscopic cholecystectomy in a patient with myotonic dystrophy. J R Soc Med 2004;97:284-285.

  19. El-Dawlatly AA, Aldohayan A, Nawaz S, Alshutry A. Anesthetic management of a patient with myotonic dystrophy for laparoscopic cholecystectomy. A case report. M.E.J. Anesth 2008;19:1135-1140.

  20. Khan Joad AS, Saxena MV. Anaesthesia for myotonic dystrophy. J. Anaesth Clin Pharmacol 2005;21:199-201.

  21. Contreras G. Uso de relajantes en pacientes con enfermedades neuromusculares. Revista Venezolana de Anestesiología 2001;6:28-46.

  22. 22) www.myotonicdystrophy.org//anaesthetic%20Complications.htm. Acceso en noviembre 12,2008

  23. Vilaplana BJ, Villalonga MA. Capítulo 46 aspectos clínicos del uso de bloqueadores neuromusculares en enfermedades neuromusculares. En: Relajantes Musculares en Anestesia y Terapia intensiva, 2ª. Edición Arán Ediciones, 2000:599-612.

  24. Stoelting RG. Chapter 9 Anticholinesterase drugs and cholinergic agonists, pharmacology and physiology in anesthetic practice 3a. Edition 1999:224-238.

  25. Forés B, Manzano A, Urrengoetxea P, Aguilera L. Anestesia en el paciente con patología neuromuscular. Gac Med Bilbao 2006;103:79-89.

  26. Kingler B, Lehmann-Hornb F, Jurkat-Rottb K. Review complications of anaesthesia in neuromuscular disorders. Neuromuscular Disorders 2005;15:195-206.

  27. Haley FC. Anaesthesia in dystrophia/myotonia. Can Anaes Soc J 1962;9:270-275.

  28. Katz LR, Katz EL. XI Técnicas especiales capítulo 45 complicaciones relacionadas con la utilización de relajantes musculares. Complicaciones en Anestesiología. Salvat Editores, 1986:557-579.

  29. Pruzanski W. Respiratory tract infections and silent aspiration in myotonic dystrophy. Chest 1962;42:608-610.

  30. Souza FA, Bessa Jr CR, Castro CHV, Cunha MC, Santos D. Anestesia en paciente con enfermedad de Steinert. Relato de caso. Rev Bras Anestesiol 2006;56:419-421.




2020     |     www.medigraphic.com